Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation
- PMID: 1479298
Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation
Abstract
One of the major complications of allogeneic bone marrow transplantation (BMT) is graft-versus-host disease (GvHD), which is caused by donor type lymphocytes which react against the recipient's tissues. An important factor which influences GvHD is the recipient's gastrointestinal microflora. This was originally observed in gnotobiotic mice. Infusion of 10(7) H-2 incompatible bone marrow cells into lethally irradiated (9.0 Gy X-rays) conventional mice results in a late onset type GvHD which causes the death of the majority of the recipients during the first two months after BMT. This mortality can be completely prevented if the recipients are germfree mice, or when they are conventional animals which have been subjected to complete or selective gastrointestinal decontamination (GID). In a mouse model, the mechanism responsible for the influence of the microflora on GvHD after allogeneic BMT was investigated. These studies indicate that GvHD can be induced by activated T-lymphocytes from donor origin reacting against bacterial antigens which might be cross-reactive with the recipient's epithelial tissue antigens. Activation of these T-lymphocytes is confined to antigens of certain bacterial species of the recipient which are not present in the indigenous microflora of the donor mice. These bacteria most likely belong to the anaerobic flora of the recipient. The latter hypothesis is strongly supported by the observation in human patients that, in contrast to complete GID, selective decontamination of the gastrointestinal tract did not have any beneficial effect on moderately severe to severe GvHD after transplantation with MHC-matched sibling donor bone marrow grafts.
Similar articles
-
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.J Clin Invest. 1998 May 1;101(9):1835-42. doi: 10.1172/JCI1268. J Clin Invest. 1998. PMID: 9576746 Free PMC article.
-
Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.Biol Blood Marrow Transplant. 1999;5(4):222-30. doi: 10.1053/bbmt.1999.v5.pm10465102. Biol Blood Marrow Transplant. 1999. PMID: 10465102
-
Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.Biol Blood Marrow Transplant. 2003 Dec;9(12):742-52. doi: 10.1016/j.bbmt.2003.09.007. Biol Blood Marrow Transplant. 2003. PMID: 14677113
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.Front Immunol. 2024 Feb 15;15:1339971. doi: 10.3389/fimmu.2024.1339971. eCollection 2024. Front Immunol. 2024. PMID: 38426096 Free PMC article. Review.
-
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.J Clin Invest. 2001 Jun;107(12):1581-9. doi: 10.1172/JCI12156. J Clin Invest. 2001. PMID: 11413166 Free PMC article.
-
Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature.World J Clin Cases. 2023 Oct 6;11(28):6908-6919. doi: 10.12998/wjcc.v11.i28.6908. World J Clin Cases. 2023. PMID: 37901004 Free PMC article.
-
Intestinal permeability defects: is it time to treat?Clin Gastroenterol Hepatol. 2013 Sep;11(9):1075-83. doi: 10.1016/j.cgh.2013.07.001. Epub 2013 Jul 12. Clin Gastroenterol Hepatol. 2013. PMID: 23851019 Free PMC article. Review.
-
The role of bacteria and pattern recognition receptors in GVHD.Int J Inflam. 2010 Oct 31;2010:814326. doi: 10.4061/2010/814326. Int J Inflam. 2010. PMID: 21188220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials